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Abstract
Our	 lab	aims	to	systematically	 identify	 the	structural	elements	of	
chondroitin	sulfate	proteoglycans	(CSPGs)	that	inhibit	regeneration	
following	spinal	cord	injury	(SCI).		CSPGs	are	extracellular	matrix	
molecules	produced	by	astrocytes	of	glial	scar	tissue	following	SCI.	
Central	to	this	project	is	the	use	of	CSPGs	referred	to	as	“Designer	
PGs,”	which	contain	engineered	modifications	in	the	GAG	chains	and/
or	the	protein	core	of	the	neural	CSPG	aggrecan.		Using	established	
bioassays	in	vitro,	we	qualitatively	and	quantitatively	measure	growth	
cone	behaviors	and	morphology	as	they	interact	with	Designer	PG	
molecules.		These	measurements	are	then	translated	into	a	composite	
inhibitory	quotient	(IQ)	score	that	reflects	the	inhibitory	strength	of	
the	particular	Designer	PG.		Scoring	is	completed	through	applica-
tion	of	our	comprehensive	inhibitory	quotient	(IQ)	system	scoring	
criteria.		The	utility	of	the	IQ	system	is	that	it	allows	us	to	evaluate	
and	directly	compare	all	experimental	CSPGs.		IQ	scores	can	then	
be	mapped	back	to	the	structure	of	the	experimental	CSPG,	allowing	
us	to	pinpoint	the	inhibitory	domains	of	CSPGs.		The	long	term	goal	
of	this	methodology	is	to	develop	clinical	therapies	that	selectively	
target	the	most	inhibitory	CSPG	domains	while	leaving	unaltered	the	
beneficial	aspects	of	the	glial	scar,	thereby	supporting	regeneration	
and	recovery	of	function	following	SCI.
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entitled,	“Quantification	of	Neuronal	Growth	Cone	Responses	to	Specific	Chondroitin	Sulfate	Proteoglycan	Motifs”	has	been	extremely	
challenging	and	represents	a	mature	endeavor,	even	for	more	advanced	students.		Eddie	has	been	diligent	from	day	one	and	has	done	
an	amazing	job,	accumulating	data,	critically	analyzing	the	data,	and	
presenting	the	results	at	a	variety	of	meetings	both	local	and	national.	
From	observing	Eddie	as	he	progresses	through	this	study,	it	is	clear	
that	he	is	very	intelligent,	highly-motivated,	mature	beyond	his	years,	
and	capable.	 	 I	have	been	very	impressed	with	Eddie’s	work	ethic	and	
drive	as	he	has	analyzed	neuronal	growth	cone	behavior	in	response	to	
inhibitory	proteoglycans.	This	project	requires	great	attention	to	detail,	
and	extreme	accuracy,	as	well	as	long	hours	of	analysis.	 	Eddie	has	
given	100%	on	all	accounts.		The	article	he	is	currently	submitting	to	
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of	the	project	he	has	done.	The	depth	and	breadth	of	inquiry	he	
describes	demonstrate	his	integral	involvement	in	the	project	
and	his	abundant	academic	talents.			
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Introduction
Spinal	cord	injury	(SCI)	is	a	debilitating	condition	currently	afflicting	ap-
proximately	255,000	people	in	the	U.S.	alone	(NSCISC,	2008).	This	condi-
tion	 presents	 formidable	 challenges	 to	 successful	 post-trauma	 recovery	
of	function	and	often	results	in	permanent	central	nervous	system	(CNS)	
damage.	A	hallmark	of	regeneration	failure	following	SCI	is	the	up-regula-
tion	of	inhibitory	chondroitin	sulfate	proteoglycans	(CSPGs)	by	astrocytes	
of	the	glial	scar	(Fitch	and	Silver,	2008).	One	member	of	the	CSPG	family	
that	is	up-regulated	is	aggrecan	(Figure	1),	which	can	serve	as	a	model	for	
this	family	of	aggregating	proteoglycans.	Although	studies	in	vitro	and	in	
vivo	have	localized	the	inhibition	largely	to	the	glycosaminoglycan	(GAG;	
sugar)	portion	of	CSPGs	(Snow	et	al.,	1990),	the	specific	parts	of	the	GAG	
chains	or	possible	protein	domains	responsible	for	inhibition	remain	un-
identified.	Further,	the	effects	of	specific	CSPG	motifs	on	neuronal	growth	
cone	behaviors	have	yet	to	be	systematically	quantified.	
In	the	present	study,	we	are	identifying	the	precise	structural	microhet-
erogeneities	of	CSPGs	that	make	them	inhibitory	to	neuronal	growth	cones,	
using	a	novel	technique	involving:	1)	“Designer	PGs”	and,	2)	an	“Inhibitory	
Quotient	(IQ)”	analysis	system.	Designer	PGs	are	discrete	aggrecan	mutants	
that	are	produced	with	altered	properties	(elimination	of	specific	sites	for	
glycosylation,	alterations	in	sugar	chain	length,	or	number,	composition,	or	
deletion	of	individual	domains)	to	identify	modifications	affecting	neurite	
outgrowth.	With	the	IQ	system,	a	wide	variety	of	behavioral	and	morphologi-
cal	parameters	of	neuronal	growth	cones	are	qualitatively	and	quantitatively	
evaluated	from	time-lapse	images	as	growth	cones	contact	and	respond	to	
Designer	PGs.	The	IQ	system	is	then	used	to	translate	these	responses	into	
composite	IQ	scores	for	each	Designer	PG,	which	is	an	indication	of	the	
degree	of	inhibitory	strength	of	each	PG	(see	Methods).	
The	results	of	this	on-going	study	are	serving	to	identify	the	structural	
moieties	responsible	 for	 the	 inhibitory	action	of	CSPGs,	and	are	provid-
ing	insight	into	the	ways	in	which	growth	cones	respond	to	proteoglycan	
molecules.	The	long-term	goal	of	these	studies	is	to	develop	strategies	to	
manipulate	the	most	inhibitory	domains	of	CSPGs	to	render	them	non-
inhibitory.		In	this	way,	glial	scars	will	remain	intact	to	facilitate	the	normal	
healing	and	repair	processes,	but	CSPGs	will	allow	regeneration,	ultimately	
promoting	recovery	of	function	in	patients	with	SCI.
Methods:
Bioassays
Sensory Neuron (DRG) Dissection
Embryonic	dorsal	root	ganglia	(DRG)	neurons	were	dissected	on	ice	ac-
cording	to	AAALAC	regulations	governing	animal	welfare	and	transferred	
to	culture	dishes	containing	500	µl	of	Dulbecco’s	Modified	Eagle	Media	
(DMEM)	with	F12	HEPES	in	a	1:1	ratio.	The	DRG	were	cut	into	small	explants	
and	plated	on	the	substratum	described	below.	The	substratum	plates	were	
incubated	at	37°C	for	~6	hr.
Substratum Preparation 	
Glass	coverslips	were	mounted	over	holes	in	the	bottom	
of	50	mm	polystyrene	Petri	dishes.		A	0.1	mg/ml	poly	
L-lysine	solution	was	applied	to	the	coverslip	to	provide	
an	adhesive	surface	for	the	binding	of	other	molecules	
of	interest.		The	glass	coverslips	were	then	washed	two	
times	with	PBS	and	allowed	to	dry.	Purified	CSPGs	were	
applied	using	cellulose	strips	(Whatman	filter	paper)	in	
a	pattern	onto	the	poly	L-lysine	background	(Modifica-
tion	of	Snow	et	al.,	2002).	 	Laminin	(25	µg/ml)	was	
then	applied	to	the	entire	coverslip,	and	incubated	at	
room	temperature	for	1	hr.		The	substratum	was	then	
washed	 to	 remove	unbound	 laminin	 or	CSPGs	 from	
the	substratum.	The	result	was	a	patterned	substratum	
consisting	of	alternating	stripes	of	adsorbed	CSPGs	and	
laminin.		(Figure	2)	
Growth Cone Parameter Analysis
Growth Cone Measurements
A	Zeiss	Axiovison	image	analysis	system	was	used	to	
record	time-lapse	videos	of	individual	DRG	neurons	as	
they	approached	and	contacted	CSPG	stripes.		The	videos	
were	then	reviewed	frame	by	frame	and	used	to	record	
measurements	of	numerous	outgrowth	parameters,	with	
particular	emphasis	on	the	behavior	of	the	leading	“ex-
ploratory”	component	of	the	DRG	neurons,	called	the	
growth	cone	(GC)	(Figure	3	and	Table	1).
Figure 1: Native Aggrecan. 
Figure 2:  Stripe Bioassay
Figure 3: Growth Cone Measurement Analysis
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GROWTH CONE MORPHOLOGY GROWTH CONE BEHAVIOR
Growth	Cone	Area	 	 	 Growth	on	PG	Stripe
Growth	Cone	Length	 	 	 Growth	Rate
Growth	Cone	Width	 	 	 Growth	Cone	Acceleration
Number	of	Filopodia	 	 	 Growth	Cone	Retraction
Max	Filopodial	Length	 	 	 Growth	Cone	Turning
Total	Length	of	Filopodia	 	 	 Growth	Cone	Branching
Each	of	these	GC	parameters	was	measured	in	four	dif-
ferent	zones	of	neuronal	outgrowth	relative	to	the	PG-
adsorbed	stripe.		Note	that	Zone	1	neuronal	responses	
were	taken	as	the	baseline	values,	as	no	contact	with	
the	experimental	CSPG	is	made	throughout	this	zone.	
(Figure	4)	
Inhibitory Quotient (IQ) System
Quantitative Assessment of Inhibition
The	IQ	system	is	a	novel	method	by	which	to	translate	
measurements	 of	 growth	 cone	 responses	 to	Designer	
PGs	into	a	quantitative,	composite	IQ	score	for	each	PG,	
to	reflect	the	degree	of	inhibitory	strength	of	each	PG	
tested.		To	set	the	criteria,	two	PG	standards	were	used	
that	 represent	 the	 extremes	of	 growth	 cone	behavior	
in	response	to	this	class	of	molecule:	1)	bovine	[adult]	
articular	cartilage	aggrecan	(Sigma	#A1960),	which	is	
highly	decorated	with	GAG	chains	and	induces	complete	
inhibition	of	growth	cone	elongation;	and	2)	recombi-
nant	aggrecan	expressed	in	the	cell	line	CHO-745,	which	
is	deficient	in	xylosyl	transferase,	thus	the	CSPG	is	de-
void	of	GAG	chains,	and	is	completely	non-inhibitory	
to	growth	cone	elongation.		Growth	cone	responses	to	
these	two	molecules	set	the	criteria	for	analysis	of	all	
Table 2: IQ System Scoring Criteria
Figure 4:  Four Zones of Outgrowth on Patterned 
Substratum in Assays in vitro
Table 1:  Partial List of Growth Cone Parameters 
Measured
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5B
Figure 5(A-B): Growth Cone Width and Area are 
Reliable Predictors of CSPG Inhibition.
subsequent	Designer	PGs,	e.g.,	COS-7-derived	aggrecan	
(see	Results).
Development	of	 the	 criteria	 (Table	2)	 for	 growth	
cone	analysis	required	calculation	of	a	single	X	and	Y	
value	for	each	of	the	two	control	PGs	for	every	parameter.	
X	and	Y	values	summarize	all	experiments	for	a	given	
PG	(n=3)	and	represent	changes	in	behavior	compared	
to	growth	on	laminin	alone	(zone	1):
Comparison of behaviors in Zone 2 to Zone 1:  
[ Avg. Z2/Z1 = X ]  (n=3)
Comparison of behaviors in Zone 3 to Zone 1:  
[ Avg. Z3/Z1 = Y ]  (n=3)
Because	the	inhibitory	trends	for	a	given	parameter	were	
reflected	in	the	X	and	Y	values	for	each	standard	PG,	a	
quantifiable	basis	for	criteria	development	was	estab-
lished.		Individual	criteria	were	developed	separately	for	
zone	2	and	zone	3	trends	for	each	parameter	and	a	point	
value	of	0-2	was	given	depending	on	the	extent	to	which	
the	X	and	Y	values	reflected	inhibitory	responses	(0	=	
least	inhibitory,	2	=	most	inhibitory).		The	criteria	for	
each	parameter	are	integrated	into	category	scores	and	
then	combined	into	a	comprehensive	scoring	criterion	
that	yields	a	composite	IQ	score	ranging	from	0-30	(least	
to	most	 inhibitory).	 	Although	 the	 raw	data	 become	
compressed,	the	utility	of	the	scoring	criteria	and	com-
putation	of	X	and	Y	values	is	that	they	can	be	used	to	
assign	a	composite	IQ	score	to	any	experimental	CSPG.	
Further,	raw	data	is	still	taken	into	consideration,	as	is	
qualitative	data	for	each	growth	cone’s	response.	
Results:
Growth Cone Behaviors Reflect the Degree of CSPG-
Induced Inhibition
(Figure	5A)		For	the	growth	cone	width	parameter,	both	
the	X	values	(p	=	0.027,	t	test)	and	the	Y	values	(p	=	
0.011,	 t	 test)	are	 significantly	different	 for	 the	bovine	
aggrecan	positive	control	and	the	CHO	745	negative	con-
trol.		Such	differences	were	quantified	and	incorporated	
into	the	IQ	scoring	criteria.		(Figure	5B)		Y	values	for	both	
the	positive	and	negative	CSPG	controls	reveal	significant	
differences	(p	=	0.039,	t	test)	in	growth	cone	area.
Composite IQ Scores Differ Between Designer 
PGs
The	IQ	system	is	sensitive	in	distinguishing	the	inhibitory	
capacity	of	three	CSPGs	with	very	different	properties.	
The	“COS-7	Designer	PG”	is	a	mutant	form	of	aggrecan	
(see	Methods).		Note	that	its	inhibitory	properties	are	
somewhat	 intermediate	 between	 those	 of	 bovine	 ag-
grecan	and	CHO-745	CSPGs.	(Figure	6)Figure 6: Composite IQ Scores for Three CSPGs.
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Discussion:
Two	 important	 conclusions	 immediately	 follow	 from	
this	work.		First,	select	behavioral	and	morphological	
parameters	of	DRG	neurons	are	 reliable	predictors	of	
CSPG-induced	 inhibition.	 	 This	 finding	was	 readily	
shown	 by	 the	 statistically	 significant	 differences	 in	
responses	of	neurons	to	the	bovine	aggrecan	and	CHO-
745	CSPG	standards	for	the	parameters,	“growth	cone	
area”	and	“growth	cone	width.”		Significant	differences	
were	also	observed	for	a	number	of	other	growth	cone	
parameters,	reinforcing	the	notion	that	such	parameters	
reflect	the	inhibitory	capacity	of	CSPGs.		
Second,	 the	 differences	we	 observed	 for	 growth	
cone	responses	to	various	CSPGs	can	be	quantified	and	
incorporated	 into	 a	 comprehensive	 scoring	 criterion.	
Because	the	two	CSPG	standards	together	comprise	the	
entire	spectrum	of	inhibitory	responses	(complete	inhibi-
tion	to	no	inhibition),	values	calculated	for	the	bovine	
aggrecan	established	the	criteria	for	maximum	inhibition	
and	values	for	CHO-745	CSPG	established	criteria	for	
minimum	inhibition.		Values	intermediate	to	those	ob-
served	for	the	two	standard	CSPGs	were	assigned	scores	
indicating	intermediate	inhibitory	effects.		Extension	of	
this	analysis	to	several	other	growth	cone	parameters	
then	 facilitates	 calculation	 of	 category	 scores,	which	
are	then	combined	to	ultimately	give	the	composite	IQ	
score.		The	IQ	system	thus	allows	for	the	evaluation	of	
any	experimental	CSPG	(“Designer	PG”).
A	third	result	of	this	study	thus	far	that	is	quite	in-
triguing	and	novel	in	the	field	is	that	a	blinded	statistical	
analysis	of	the	linear	data	for	growth	cone	behaviors	in	
response	to	CPSGs	showed	that	values	related	to	growth	
cone	morphology	significantly	changed	in	the	frame	just	
following	single	filopodial	contact	with	the	inhibitor.		For	
many	years,	researchers	have	questioned	whether	there	
is	a	cell	surface	receptor	for	CSPGs,	with	no	resulting	data	
to	date	to	support	this	theory.		That	a	cell	can	change	its	
morphology	immediately	following	contact	with	a	single	
filopodium	suggests	that	a	receptor-mediated	event	is	
not	out	of	the	question,	and	supports	further	research	in	
this	regard.		However,	an	alternative	explanation	might	
be	effects	of	charge	density,	given	the	large	degree	of	
sulfation	of	CPSGs,	or	regulation	of	calcium-mediated	
events	(Snow	et	al.,	1992).		These	possibilities	remain	
to	be	tested.
The	IQ	system	analysis	is	not	only	consistent	among	
different	PG	samples,	but	is	also	consistent	among	differ-
ent	users.		This	is	true	with	respect	to	both	growth	cone	
measurement	analyses	as	well	as	composite	 IQ	score	
formulation.		As	such,	it	can	be	applied	repeatedly	to	
derive	IQ	scores	for	different	CSPGs,	and	can	be	adopted	
for	use	on	a	more	universal	scale	to	test	a	wide	variety	of	
molecular	cues.		One	NIH	reviewer	of	this	project	stated	
the	methodology	“may	become	the	standard	in	the	field.”	
The	results	thus	far	support	this	prediction.
Further	 application	 of	 the	 IQ	 system	 of	 scoring	
with	several	Designer	PG	constructs	will	uncover	 the	
structural	 basis	 of	CSPG-based	 outgrowth	 inhibition.	
The	importance	of	this	work	is	underscored	by	the	fact	
that	identification	of	these	inhibitory	domains	should	
ultimately	permit	clinical	applications	to	reduce	inhibi-
tion,	promote	axonal	regeneration,	and	counteract	the	
utterly	debilitating	and	presently	irreversible	nature	of	
spinal	cord	injuries,	to	facilitate	functional	recovery.				
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